Company · Analysis · 31 Oct 2026
Ambee Pharmaceuticals: FY2025 revenue of BDT 230.6m, BDT 661.1m of 'liabilities for other finance' on BDT 32.3m of equity, and a qualified audit opinion
A 1976-incorporated Tejgaon drug maker selling tablets, capsules, liquids, ointments and ampoules: five years of filings, 9M FY2026 revenue down 40.9% on 9M FY2025, a BDT 52.6m share investment first recorded in FY2025, and FY2026 accounts not yet in the corpus at 2-Nov-2026.
Ambee Pharmaceuticals PLC was incorporated in Bangladesh as a public company on 4 February 1976, began commercial operation in 1978 and issued shares to the public in 1986; its shares are listed on the Dhaka and Chittagong stock exchanges. The registered office and the manufacturing…